Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

1.5K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.5K
Heritability01:06

Heritability

915
Heritability is a statistical concept that measures the degree to which genetic differences among individuals contribute to trait variations within a population. It is a fundamental idea in genetics, often prone to misinterpretation. Heritability is expressed as a percentage, reflecting the proportion of variation in a specific trait across a population that can be linked to genetic differences. However, it's important to understand that heritability does not determine how "genetic"...
915
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.6K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.6K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

1.1K
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.1K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

950
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
950
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

1.4K
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Obscure Small Bowel Bleeding From Visceral Kaposi Sarcoma Without Cutaneous Manifestations.

The American journal of gastroenterology·2025
Same author

All Good Things Come to an End: 5 Years at the Helm of CMGH.

Cellular and molecular gastroenterology and hepatology·2024
Same author

The Tumor Suppressor <i>Adenomatous Polyposis Coli (apc)</i> Is Required for Neural Crest-Dependent Craniofacial Development in Zebrafish.

Journal of developmental biology·2023
Same author

CMGH: The year in review.

Cellular and molecular gastroenterology and hepatology·2021
Same author

Model Organisms Help Define the ABCs of Neonatal Cholestasis.

Gastroenterology·2021
Same author

Impaired Redox and Protein Homeostasis as Risk Factors and Therapeutic Targets in Toxin-Induced Biliary Atresia.

Gastroenterology·2020

Related Experiment Video

Updated: Apr 13, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

7.7K

IBD. Fishing for missing heritability in IBD.

Michael Pack1

  • 1Department of Medicine and Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, 421 Curie Boulevard, Philadelphia, PA 19104, USA.

Nature Reviews. Gastroenterology & Hepatology
|May 6, 2015
PubMed
Summary

This study explores why genetic testing often fails to fully explain the risk of developing inflammatory bowel disease. By using zebrafish as a model, researchers discovered that changes in how the TNF gene is controlled—rather than just the gene sequence itself—may account for some of this unexplained risk. This finding suggests that environmental or chemical factors influencing gene expression could be key to understanding the disease.

Keywords:
geneticstumor necrosis factorzebrafish modeldisease inheritance

Frequently Asked Questions

More Related Videos

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
09:44

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis

Published on: October 14, 2025

605
Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
09:08

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Published on: June 2, 2021

2.2K

Related Experiment Videos

Last Updated: Apr 13, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

7.7K
Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
09:44

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis

Published on: October 14, 2025

605
Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
09:08

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Published on: June 2, 2021

2.2K

Area of Science:

  • Gastroenterology research within inflammatory bowel disease (IBD) genetics
  • Epigenetic regulation mechanisms in developmental biology

Background:

Genetic susceptibility to inflammatory bowel disease remains a complex puzzle for modern medicine. While researchers acknowledge that inherited factors drive disease risk, standard genetic models often fail to account for the total observed prevalence. This discrepancy creates a significant knowledge gap regarding the underlying causes of the condition. Prior studies have focused heavily on identifying specific DNA variants that increase individual vulnerability. That uncertainty drove scientists to look beyond simple additive risk models for more comprehensive explanations. It was already known that traditional sequencing methods frequently leave a portion of disease heritability unexplained. This study addresses that limitation by investigating alternative regulatory mechanisms that might influence disease development. No prior work had resolved how non-genetic modifications might bridge this gap in our current understanding.

Purpose Of The Study:

The aim of this study is to determine whether epigenetic regulation of the tumor necrosis factor gene contributes to the missing heritability of inflammatory bowel disease. Researchers sought to move beyond simple additive risk models to uncover hidden drivers of the condition. This investigation addresses the persistent challenge of explaining why many individuals with the disease lack known genetic variants. The team hypothesized that regulatory modifications might play a more significant role than previously recognized. By focusing on this specific gene, they intended to clarify how non-genetic factors influence disease expression. The motivation for this work stems from the limitations of current genome-wide association studies. No prior research had successfully linked these specific epigenetic shifts to the unexplained risk in this patient population. This study provides a necessary framework for understanding the complex interplay between genetics and gene control.

Main Methods:

The review approach involved utilizing a vertebrate model to examine gene control mechanisms. Investigators employed zebrafish to simulate the complex regulatory environment found in human disease. This design allowed for the systematic manipulation of gene expression patterns during early developmental stages. The team assessed how specific modifications to the genome influence the activity of the tumor necrosis factor pathway. By monitoring these changes, the researchers established a link between regulatory shifts and disease-related outcomes. This methodology avoids the limitations of purely sequence-based association studies. The approach emphasizes the functional consequences of non-coding genomic regions. Each step of the analysis focused on identifying how these regulatory elements contribute to the observed disease risk.

Main Results:

Key findings from the literature indicate that epigenetic changes in the tumor necrosis factor gene significantly impact disease susceptibility. The evidence demonstrates that these regulatory alterations account for a portion of the previously unexplained heritability. Researchers observed that the zebrafish model effectively mirrors the complex gene expression patterns associated with the condition. The data show that these modifications function independently of traditional genetic risk factors. This finding suggests that the regulatory landscape is a critical component of disease inheritance. The results highlight a clear connection between gene control and the manifestation of the disease phenotype. These observations provide a robust basis for shifting the focus toward non-genetic regulatory mechanisms. The study confirms that these epigenetic shifts offer a plausible explanation for the missing heritability in the population.

Conclusions:

The authors propose that epigenetic modifications of the tumor necrosis factor gene represent a potential source of missing heritability. This synthesis suggests that disease risk involves more than just inherited DNA sequences. The findings imply that regulatory changes might be as impactful as direct genetic mutations. Researchers highlight that zebrafish models provide a clear window into these complex biological processes. The implications of this work point toward a broader view of how environmental influences shape disease expression. By focusing on gene regulation, the team offers a new perspective on why some individuals develop the condition despite lacking known risk variants. This review of the evidence indicates that future investigations should prioritize epigenetic pathways. The study concludes that understanding these regulatory shifts is vital for clarifying the full spectrum of disease inheritance.

The researchers propose that epigenetic regulation of the tumor necrosis factor gene influences disease risk. This mechanism acts independently of traditional additive genetic variants, potentially explaining the missing heritability observed in clinical populations.

The team utilized zebrafish as an experimental model. These organisms serve as a platform to observe how gene expression changes during development, offering insights into regulatory processes that are difficult to track in human subjects.

Zebrafish are necessary because they allow for the observation of real-time gene regulation during embryonic development. This model provides a controlled environment to isolate how specific epigenetic shifts affect the tumor necrosis factor pathway.

The authors rely on this data to demonstrate that regulatory modifications, rather than just DNA sequence changes, drive disease-related phenotypes. This approach shifts the focus from static genetic markers to dynamic gene control mechanisms.

The researchers measured the expression levels of the tumor necrosis factor gene. They observed that alterations in the epigenetic state of this gene correlate with phenotypic changes, suggesting a direct link to disease susceptibility.

The authors claim that their findings provide a foundation for re-evaluating the genetic architecture of the disease. They suggest that future research must integrate epigenetic data to fully map the landscape of inherited risk.